Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs

Journal of Applied Physiology

Volumn 98, Issue 3, 2005, Pages 930-939

  Christopher, Michael J ^a,b   Rantzau, Christian ^a,b   McConell, Glenn ^b   Kemp, Brace E ^c   Alford, Frank P ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Free fatty acids; Glucose uptake; Metabolic clearance rate of glucose; Phlorizin induced normoglycemia; Plasma derived glycolysis; Skeletal muscle

Indexed keywords

ALLOXAN; FATTY ACID; GLUCOSE; PHLORIZIN;

ALLOXAN DIABETES MELLITUS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HYPERGLYCEMIA; LIVER METABOLISM; MALE; METABOLIC CLEARANCE RATE; MUSCLE BIOPSY; NONHUMAN; PLASMA; PLASMA DERIVED GLYCOLYSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; SKELETAL MUSCLE; TREADMILL EXERCISE; VASTUS LATERALIS MUSCLE;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOGS; DRUG COMBINATIONS; EXERCISE TEST; EXERTION; FATTY ACIDS, NONESTERIFIED; GLUCOSE; HOMEOSTASIS; HYPERGLYCEMIA; MEN; MUSCLE, SKELETAL; PHLORHIZIN;

EID: 14144255136     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00687.2004     Document Type: Article

References (57)

1. Bak JF, Jacobsen UK, Jorgensen FS, and Pedersen O. Insulin receptor function and glycogen synthase activity in skeletal muscle biopsies from patients with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 69: 158-164, 1989.
2. Brand CL, Jorgensen PN, Svendsen I, and Holst JJ. Evidence for a major role for glucagon in regulation of plasma glucose in conscious, non-diabetic and alloxan-induced diabetic rabbits. Diabetes 45: 1076-1083, 1996.
3. Caruso G, Proietto J, Calenti A, and Alford F. Insulin resistance in alloxan-diabetic dogs: evidence for reversal following insulin therapy. Diabetologia 25: 273-279, 1983.
4. Challis RAJ, Vranic M, and Radda GK. Bioenergetic changes during contraction and recovery in diabetic rat skeletal muscle. Am J Physiol Endocrinol Metab 256: E129-E137, 1989.
5. Christopher MJ, Chen ZP, Rantzau C, Kemp BE, and Alford FP. Skeletal muscle basal AMP-activated protein kinase activity is chronically activated in alloxan-diabetic dogs: impact of exercise. J Appl Physiol 95: 1523-1530, 2003.
6. Christopher MJ, Rantzau C, Ward GM, and Alford FP. Impact of variable insulinemia and glycemia on in vivo glycolysis and glucose storage in dogs. Am J Physiol Endocrinol Metab 266: E62-E71, 1994.
7. Christopher MJ, Rantzau C, Ward GM, and Alford FP. Hypoinsulinemia and hyperglycemia influence the in vivo partitioning of GE and SI. Am J Physiol Endocrinol Metab 268: E410-E421, 1995.
8. Christopher MJ, Sleeman MW, Alford FP, and Best JD. Contrasting action of short and long-term adrenaline infusion on dog skeletal muscle glucose metabolism. Diabetologia 35: 399-405, 1992.
9. Coker RH, Krishna MG, Brooks Lacy D, Allen EJ, and Wasserman DH. Sympathetic drive to liver and nonhepatic splanchnic tissue during heavy exercise. J Appl Physiol 82: 1244-1249, 1997.
10. Crowther GJ, Milstein JM, Jubrias SA, Kushmerick MJ, Gronka RK, and Conley KE. Altered energetic properties in skeletal muscle of men with well-controlled insulin-dependent (Type 1) diabetes. Am J Physiol Endocrinol Metab 284: E655-E662, 2003.
11. Del Prato S, Bonadonna RC, Bonora E, Gulli G, Solini A, Shank M, and DeFronzo RA. Characterization of cellular defects of insulin action in Type 2 (non-insulin-dependent) diabetes mellitus. J Clin Invest 91: 484-494, 1993.
12. Dimitrakoudis D, Ramlal T, Rastogi S, Vranic M, and Klip A. Glycemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle. Biochem J 284: 341-348, 1992.
13. Douen AG, Ramlal T, Rastogi S, Bilan PJ, Cartee GD, Vranic M, Holloszy JO, and Klip A. Exercise induces recruitment of the "insulin responsive glucose transporter." Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle. Biol Chem 265: 13427-13430, 1990.
14. Fisher SJ, Lekas M, Shi ZQ, Bilinski D, Carvalho G, Giacca A, and Vranic M. Insulin-dependent acute restoration of euglycemia normalises the impaired glucose clearance during exercise in diabetic dogs. Diabetes 46: 1805-1812, 1997.
15. Fueger PT, Bracy DP, Malabanan CM, Pencek RR, and Wasserman DH. Distributed control of glucose uptake in working muscles of conscious mice: roles of transport and phosphorylation. Am J Physiol Endocrinol Metab 286: E77-E84, 2004.
16. Goodyear LJ, Hirshman MF, King PA, Thompson CM, Horton ED, and Horton ES. Skeletal muscle plasma membrane glucose transport and glucose transporters after exercise. J Appl Physiol 68: 193-198, 1990.
17. Hagenfeldt L. Metabolism of free fatty acids and ketone bodies during exercise in normal and diabetic man. Diabetes 28: 66-70, 1979.
18. Hagg SA, Taylor SI, and Ruderman NB. Glucose metabolism in perfused skeletal muscle: pyruvate dehydrogenase in starvation, diabetes and exercise. Biochem J 158: 203-210, 1976.
19. Hew FL, Koschmann M, Christopher M, Rantzau C, Vaag A, Ward G, Beck-Nielsen H, and Alford F. Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab 81: 555-564, 1996.
20. Hother-Nielsen O, Henriksen JE, Holst JJ, and Beck-Nielsen H. Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique. Metabolism 45: 82-91, 1996.
21. Katz A, Raz I, Spenser MK, Rising R, and Mott DM. Hyperglycemia induces glucose accumulation in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 260: R698-R705, 1991.
22. Kennedy JW, Hirshman MF, Gervino EV, Ocel JV, Forse RA, Hoenig SJ, Aronson D, Goodyear LJ, and Horton ES. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with Type 2 diabetes. Diabetes 48: 1192-1197, 1999.
23. Hip A, Marette A, Dimitrakoudis D, Ramlal T, Giacca A, Shi ZQ, and Vranic M. Effect of diabetes on glucoregulation. From glucose transporters to glucose metabolism in vivo. Diabetes Care 15: 1747-1766, 1992.
24. Martin IK, Weber KM, Boston RC, Alford FP, and Best JD. Effects of epinephrine infusion on determinants of intravenous glucose tolerance in dogs. Am J Physiol Endocrinol Metab 255: E668-E673, 1988.
25. McConell GK, Canny BJ, Daddo MC, Nance MJ, and Snow RJ. Effect of carbohydrate ingestion on glucose kinetics and muscle metabolism during intense endurance exercise. J Appl Physiol 89: 1690-1698, 2000.
26. Nankervis A, Proietto J, Aitken P, and Alford FP. Impaired insulin activation in newly diagnosed Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 27: 497-503, 1984.
27. Nankervis A, Proietto J, Aitken P, Harewood M, and Alford F. Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes. Diabetologia 23: 320-325, 1982.
28. Nuutila P, Peltoneimi P, Oikonen V, Larmola K, Kemppainen J, Takala T, Sipila II, Oksanen A, Ruotsalainen U, Bollie GB, and Yki-Jarvinen H. Enhanced stimulation of glucose uptake by insulin increases exercise-stimulated glucose uptake in skeletal muscle in humans. Diabetes 49: 1084-1091, 2000.
29. Peltoneimi P, Yki-Jarvinen H, Oikonen V, Oksanen A, Takala TO, Ronnemaa T, Erkinjuntti M, Knuuti MJ, and Nuutila P. Resistance to exercise-induced increase in glucose uptake during hyperinsulinemia in insulin resistant skeletal muscle of patients with Type 1 diabetes. Diabetes 50: 1371-1377, 2001.
30. Peters SJ, Harris RA, Wu P, Pehleman TL, Heigenhauser GJF, and Spriet LL. Human skeletal muscle PDH kinase activity and isoform expression during 3 days of a high fat low CHO diet. Am J Physiol Endocrinol Metab 281: E1151-E1158, 2001.
31. Ploug T, Galbo H, Ohkuwa T, Tranum-Jensen J, and Vinten J. Kinetics of glucose transport in rat skeletal muscle membrane vesicles: effects of insulin and contractions. Am J Physiol Endocrinol Metab 262: E700-E711, 1992.
32. Poulin RA, Steil GM, Moore DM, Ader M, and Bergman RN. Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes 43: 180-190, 1994.
33. Putman CT, Jones NL, Lands LC, Bragg TM, Hollidge-Horvat MG, and Heigenhauser GJ. Skeletal muscle pyruvate dehydrogenase activity during maximal exercise in humans. Am J Physiol Endocrinol Metab 269: E458-E468, 1995.
34. Raguso CA, Coggan AR, Castaldelli A, Sidossis LS, Bastyr EJ, and Wolfe RR. Lipid and carbohydrate metabolism in IDDM during moderate and intense exercise. Diabetes 44: 1066-1074, 1995.
35. Randle PJ, Garland PB, Hales CN, and Newsholme EA. The glucose-fatty acid cycle: its role in insulin sensitivity and metabolic disturbances of diabetes. Lancet 1: 785-789, 1963.
36. Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E, and Wolfe RM. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol Endocrinol Metab 265: E380-E391, 1993.
37. Rossetti L and Giaccari A. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J Clin Invest 85: 1785-1792, 1990.
38. Rossetti L, Giaccari A, and De Fronzo RA. Glucose toxicity. Diabetes Care 13: 610-630, 1990.
39. Rossetti L, Smith D, Shulman GI, Papachristou D, and De Fronzo RA. Correction of hyperglycemia with phlorizin normalises tissue sensitivity to insulin in diabetic rats. J Clin Invest 79: 1510-1515, 1987.
40. Schalin-Jantti C, Harkonen M, and Groop LC. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 41: 598-604, 1992.
41. Shi ZA, Yamatani K, Fisher SJ, Lavina H, Lickley A, and Vranic M. Effects of subbasal insulin infusion on resting and exercise-induced glucose turnover in depancreatectomized dogs. Am J Physiol Endocrinol Metab 264: E334-E341, 1993.
42. Sidossis LS and Wolfe RR. Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed. Am J Physiol Endocrinol Metab 270: E733-E738, 1996.
43. Sjogaard G, Adams RP, and Saltin B. Water and ion shifts in skeletal muscle of humans with intense dynamic knee extension. Am J Physiol Regul Integr Comp Physiol 248: R190-R196, 1985.
44. Sjogaard G and Saltin B. Extra- and intracellular water spaces in muscle in man at rest and with dynamic exercise. Am J Physiol Regul Integr Comp Physiol 243: R271-R280, 1982.
45. Steele R, Wall SJ, Debodo RC, and Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15-24, 1956.
46. Thiebaud D, Jacot E, DeFronzo RA, Maeder E, Jequier E, and Felber JP. The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 31: 957-963, 1982.
47. Vaag A, Alford F, Henriksen FL, Christopher M, and Beck-Nielsen H. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia 38: 326-336, 1995.
48. Vaag A, Hother-Nielsen O, Skott P, Andersen P, Richter E, and Beck-Nielsen H. Effect of acute hyperglycemia on glucose metabolism in skeletal muscles in IDDM patients. Diabetes 41: 174-182, 1992.
49. Van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH, and Wagenmakers AJ. The effects of increasing exercise intensity on muscle fuel utilization in humans. J Physiol 536: 295-304, 2001.
50. Vestergaard H, Bjorback C, Hansen T, Larsen FS, Granner DK, and Pedersen O. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. J Clin Invest 96: 2639-2645.
51. Wahren J, Hagenfeldt L, and Felig P. Splanchnic and leg exchange of glucose, amino acids and free fatty acids during exercise in diabetes mellitus. J Clin Invest 55: 1303-1314, 1975.
52. Wasserman DH, Mohr T, Kelly P, Lacy DB, and Bracy D. Impact of insulin deficency in glucose fluxes and muscle glucose metabolism during exercise. Diabetes 41: 1229-1238, 1992.
53. Yamatani K, Shi ZQ, Giacca A, Guata R, Fisher SJ, Lickley L, and Vranic M. Role of FFA-glucose cycle in glucoregulation during exercise in the total absence of insulin. Am J Physiol Endocrinol Metab 263: E646-E653, 1992.
54. Yki-Jarvinen H and Koivisto VA. Insulin sensitivity in newly diagnosed Type 1 diabetics after keto acidosis and after 3 months of insulin therapy. J Clin Endocrinol Metab 59: 371-378, 1984.
55. Yki-Jarvinen H, Sahlin K, Ren JM, and Koivisto VA. Localisation of the rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant Type 1 diabetic patients. Diabetes 30: 157-167, 1990.
56. Zinker BA, Lacy DB, Bracy D, Jacobs J, and Wasserman DH. Regulation of glucose uptake and metabolism by working muscle. An in vivo analysis. Diabetes 42: 956-965, 1993.
57. Zinman B, Marliss EB, Hanna AK, Minuk HL, and Vranic M. Exercise in diabetic man: glucose turnover and free insulin responses after glycemic normalisation with intravenous insulin. Can J Physiol Pharmacol 60: 1236-1240, 1982.